Clinical Trials on Yeast Infection Skin in Canada

Total 6782 results

University of Toronto

Unknown

Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination

Skin Infection

Canada
The Hospital for Sick Children
University of Calgary

Completed

Medi-Port Pilot Randomized Controlled Trial

Actively Undergoing Cancer Treatment | 4-9 Years of Age | At Least 1 Month From Diagnosis | Able to Speak and Understand English | Presenting to Clinic for at Least a 2nd Subcutaneous Port Needle Insertion

Canada
University of Toronto

Completed

Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

HIV Infections | Herpes Simplex Type Two Infection

Canada
GlaxoSmithKline

Active, not recruiting

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Herpes Zoster

Spain, Canada, Belgium, Finland, Korea, Republic of, Panama, Taiwan
Fraser Health

Withdrawn

Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections (ToPICL)

Skin Diseases, Infectious | Blood Stream Infections

Canada
Sunnybrook Health Sciences Centre

Recruiting

CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee (CLEANJoint)

Aseptic Revision Total Hip Arthroplasty | Total Knee Arthroplasty With Exchange of at Least One Prosthetic Component

Canada
PolyMedix, Inc.

Completed

Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus

Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA) | (Susceptible or Methicillin Resistant)

Canada, Russian Federation, Ukraine
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

Herpes Zoster

Russian Federation, Canada
Vancouver Island Health Authority

Recruiting

Ceftriaxone as Home IV for Staph Infections

Abscess | Staphylococcal Infections | Diabetic Foot Infection | Osteomyelitis | Vertebral Osteomyelitis | CNS Infection | Septic Arthritis | Coagulase Negative Staphylococcal Infection

Canada
University of Washington
National Institutes of Health (NIH)

Terminated

A Study of HSV Testing Among Pregnant Women

Pregnancy | Herpes Simplex

Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Herpes Zoster

Spain, Taiwan, Italy, Canada, Belgium, Finland, Korea, Republic of, Panama, Czechia
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

Herpes Zoster | Herpes Zoster Vaccine

United States, Estonia, Canada
GlaxoSmithKline

Completed

Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age

Herpes Zoster | Herpes Zoster Vaccine

United States, Canada, Belgium
Université de Montréal
Stryker Trauma GmbH; Hopital du Sacre-Coeur de Montreal

Recruiting

Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery (PAPA)

Propionibacterium Infection

Canada
Boehringer Ingelheim

Recruiting

A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

Hidradenitis Suppurativa (HS)

Canada
CHU de Quebec-Universite Laval

Terminated

The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis

Herpes Simplex Keratitis

Canada
9305-9954 Quebec Inc

Unknown

The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis

Onychomycosis

Canada
Innovaderm Research Inc.
Merck Sharp & Dohme LLC

Terminated

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Psoriasis

Canada
Affinium Pharmaceuticals, Ltd

Completed

A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci

Cellulitis | Wound Infection | Skin and Subcutaneous Tissue Bacterial Infections | Cutaneous Abscess | Burn Infection

United States, Canada
Mediprobe Research Inc.
Emblation Limited

Recruiting

Pilot Study of Swift Microwave Device for Onychomycosis

Onychomycosis of Toenail

Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Herpes Zoster

United States, Germany, Estonia, Canada
Laboratoire Boreaderme Inc.

Unknown

Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis

Herpes Labialis

Canada
ToeFX Inc.

Active, not recruiting

Light Therapy for Onychomycosis Study

Onychomycosis of Toenail

Canada
Fraser Health

Completed

Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue Infections (VOD)

Skin and Soft Tissue Infections

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Skin Diseases, Bacterial

Hong Kong, Korea, Republic of, United States, Philippines, Singapore, Canada, Thailand, Israel, Taiwan, Lebanon, Malaysia, South Africa
University Health Network, Toronto

Completed

Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients

Varicella Zoster Vaccine

Canada
Nitric Solutions Inc.

Completed

Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot

Tinea Pedis

Canada
AiCuris Anti-infective Cures AG
Medpace, Inc.

Recruiting

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1)

HSV Infection

United States, Italy, Belgium, France, United Kingdom, Germany, Switzerland, Argentina, Australia, Georgia, Greece, Mexico, Israel, Canada
Deepali Kumar

Unknown

Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation

Varicella Zoster Vaccine

Canada
Sanotize Research and Development corp.

Completed

Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Verruca Plantaris

Canada
University of Manitoba
Pfizer

Terminated

Amphotericin-B and Voriconazole for Pulmonary Blastomycosis (BLASTO)

Blastomycosis

Canada
Nitric BioTherapeutics, Inc

Completed

Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)

Tinea

Canada
U.S. Army Medical Research and Development Command

Completed

Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama

Leishmaniasis, Cutaneous

Panama
CanSino Biologics Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Herpes Zoster

Canada
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

Herpes Zoster

Germany, Canada, United States
The Hospital for Sick Children

Completed

The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation

Organ Transplantation | Immunosuppression

Canada
CHU de Quebec-Universite Laval

Completed

Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy

Breast Cancer

Canada
Kymera Therapeutics, Inc.
York Dermatology Clinic and Research Centre

Completed

Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis

Dermatitis, Atopic | Hidradenitis Suppurativa

Canada
Innovaderm Research Inc.

Recruiting

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Plaque Psoriasis | Atopic Dermatitis | Hidradenitis Suppurativa | Palmoplantar Pustulosis | Acne | Chronic Hand Eczema

Canada
University of Alberta

Completed

IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT (IMPACT)

Rheumatoid Arthritis | Psoriatic Arthritis | Covid-19 Infection | Hydroxychloroquine

Canada
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR); University of Toronto

Completed

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2? (VALIANT Pilot)

Herpes Simplex | Human Immunodeficiency Virus

Canada
U.S. Army Medical Research and Development Command

Completed

Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama

Cutaneous Leishmaniasis

Panama
Western University, Canada
Lawson Health Research Institute

Withdrawn

NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT (NPWTinDIEP)

Breast Cancer | Surgical Site Infection | Wound Dehiscence

Canada
University of British Columbia
British Columbia Centre for Disease Control

Terminated

A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts

HPV | Genital Warts

Canada
University Health Network, Toronto
Oxford Immunotec

Completed

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

Tuberculosis

Canada
AbbVie

Completed

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Bacterial Infections | Staphylococcal Skin Infections | Methicillin-Resistant Staphylococcus Aureus

United States, Bulgaria, Chile, Colombia, Georgia, Greece, Guatemala, Latvia, Mexico, Panama, Spain, Ukraine
Ottawa Hospital Research Institute
The Ottawa Hospital Academic Medical Association; Canadian Association of Emergency...

Completed

High-dose vs. Standard-dose Cephalexin for Cellulitis

Cellulitis

Canada
University of British Columbia

Unknown

Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department

Cellulitis

Canada
Simon Dobson
Ministry of Health, British Columbia

Completed

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine (BCGov-01)

Cervical Cancer | Genital Warts

Canada
McMaster University
HAMSMaRT; Keeping Six; YWCA Hamilton

Not yet recruiting

The Injection-Related InfectionS (IRIS) Program (IRIS)

Infections | Peer Support | Injection-related Infections | People Who Infect Drugs (PWID)

Canada

Clinical Trials on Yeast Infection Skin in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations